Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of age on half effective dose of remazolam in gastrointestinal endoscopy
ChiCTR2100046746Phase 4Recruiting
- Sponsor
- Shidong Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam mesylate (3 arms), sponsored by Shidong Hospital. Primary endpoint: Drug dosage (half effective dose of remazolam). Started Jun 2021; status: recruiting.
02
Drugs
remimazolam mesylate
Beyond the preview
Go deeper on ChiCTR2100046746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046746.